Formestane aromatase inhibitors

CGP 32349 - CGP 32 349 - CGP-32349 - Lentaron - 4-OHA - 4-hydroxyandrostenedione - formestane



Trial Studied treatment Control Patients Size Study type Results NCT

Advanced breast cancer (metastatic) - aromatase inhibitors in all type of patients

Kleeberg, 1997formestaneanastrozoleNA
Freue, 2000formestanemegestrol acetateNA
Thuerlimann, 1997formestanemegestrol acetateNA
Perez Carrion, 1994formestanetamoxifenNA



- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons